v3.22.2.2
Revenue Recognition Disaggregation of Revenue by type of activity and reporting segment (Details) - USD ($)
$ in Millions
3 Months Ended
Sep. 30, 2022
Sep. 30, 2021
Disaggregation of Revenue [Line Items]    
Net revenue $ 1,022.0 $ 1,025.0
Biologics    
Disaggregation of Revenue [Line Items]    
Net revenue 523.0 548.0
Biologics | Manufacturing & Commercial Product Supply    
Disaggregation of Revenue [Line Items]    
Net revenue 94.0 134.0
Biologics | Development Services    
Disaggregation of Revenue [Line Items]    
Net revenue 429.0 414.0
PharmaConsumerHealth    
Disaggregation of Revenue [Line Items]    
Net revenue 499.0 477.0
PharmaConsumerHealth | Manufacturing & Commercial Product Supply    
Disaggregation of Revenue [Line Items]    
Net revenue 292.0 276.0
PharmaConsumerHealth | Development Services    
Disaggregation of Revenue [Line Items]    
Net revenue 207.0 201.0
Total Catalent before inter-segment revenue elimination    
Disaggregation of Revenue [Line Items]    
Net revenue 1,022.0 1,025.0
Total Catalent before inter-segment revenue elimination | Manufacturing & Commercial Product Supply    
Disaggregation of Revenue [Line Items]    
Net revenue 386.0 410.0
Total Catalent before inter-segment revenue elimination | Development Services    
Disaggregation of Revenue [Line Items]    
Net revenue $ 636.0 $ 615.0